Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

This study has been completed.
Information provided by:
Bristol-Myers Squibb Identifier:
First received: May 9, 2005
Last updated: April 7, 2011
Last verified: June 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)